标题
Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles
作者
关键词
-
出版物
CANCER LETTERS
Volume -, Issue -, Pages 216462
出版商
Elsevier BV
发表日期
2023-11-03
DOI
10.1016/j.canlet.2023.216462
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting ZDHHC9 potentiates anti-programmed death-ligand 1 immunotherapy of pancreatic cancer by modifying the tumor microenvironment
- (2023) Zhiqing Lin et al. BIOMEDICINE & PHARMACOTHERAPY
- Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis
- (2023) Miles Piper et al. CANCER CELL
- Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
- (2023) Eun-Kyoung Koh et al. Scientific Reports
- The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer
- (2023) Lincoln N. Strickland et al. Frontiers in Immunology
- Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice
- (2023) Kawaljit Kaur et al. Frontiers in Immunology
- A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases
- (2023) Miro E. Raeber et al. EBioMedicine
- Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report
- (2023) Xiaoting Ma et al. Frontiers in Oncology
- EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
- (2023) Loretah Chibaya et al. Nature Cancer
- Off-the-Shelf Prostate Stem Cell Antigen–Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer
- (2022) Kun-Yu Teng et al. GASTROENTEROLOGY
- Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model
- (2022) Sumit Kumar et al. GUT
- Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
- (2022) Samik Upadhaya et al. NATURE REVIEWS DRUG DISCOVERY
- iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting
- (2022) Benjamin H. Goldenson et al. Frontiers in Immunology
- Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
- (2022) Thomas Walle et al. Science Advances
- Cavitation assisted endoplasmic reticulum targeted sonodynamic droplets to enhanced anti-PD-L1 immunotherapy in pancreatic cancer
- (2022) Jifan Chen et al. JOURNAL OF NANOBIOTECHNOLOGY
- STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer
- (2022) Julia E Lefler et al. Life Science Alliance
- LncRNA NCAL1 potentiates natural killer cell cytotoxicity through the Gab2-PI3K-AKT pathway
- (2022) Chao Niu et al. Frontiers in Immunology
- Targeting myeloid suppressive cells revives cytotoxic anti-tumor responses in pancreatic cancer
- (2022) Dhifaf Sarhan et al. iScience
- CAR-NK cells: a promising cellular immunotherapy in lymphoma
- (2022) Shaghayegh Khanmohammadi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
- (2022) Christian L. Flugel et al. Nature Reviews Clinical Oncology
- Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies
- (2022) Anurag Kumar Srivastava et al. Cancers
- Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer
- (2021) Fang Sun et al. Advanced Science
- Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer
- (2021) Yang Chen et al. CANCER CELL
- Photodynamic therapy exploiting the anti-tumor activity of mannose-conjugated chlorin e6 reduced M2-like tumor-associated macrophages
- (2021) Tatsuki Soyama et al. Translational Oncology
- Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles
- (2021) Qianwen Yu et al. Acta Biomaterialia
- Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen
- (2021) Adele Gabba et al. BIOCHEMISTRY
- Delivery technologies to engineer natural killer cells for cancer immunotherapy
- (2021) Rakan El-Mayta et al. CANCER GENE THERAPY
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Overcoming the UCB HSCs –Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways
- (2021) Alireza Shokouhifar et al. Cancer Cell International
- T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
- (2021) Apostolia-Maria Tsimberidou et al. Journal of Hematology & Oncology
- Natural killer cells in pancreatic cancer stroma
- (2021) Rachel Elizabeth Ann Fincham et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment
- (2021) Ellen N. Scott et al. Frontiers in Immunology
- Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma
- (2021) Virender Kumar et al. BIOMATERIALS
- Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity
- (2021) Guy Biber et al. EMBO Molecular Medicine
- Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia
- (2021) Friederike V. Opitz et al. Cancers
- Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review
- (2020) Cao Dai Phung et al. ARCHIVES OF PHARMACAL RESEARCH
- NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms
- (2020) Stefano Regis et al. Frontiers in Immunology
- Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs
- (2020) Alicia M Chenoweth et al. IMMUNOLOGY AND CELL BIOLOGY
- 5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma
- (2020) Nancy D. Ebelt et al. Frontiers in Immunology
- You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
- (2020) Aline Pfefferle et al. Cancers
- Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment
- (2020) Young Eun Lee et al. JOURNAL OF CONTROLLED RELEASE
- Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma
- (2020) Hee Seung Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy
- (2020) Kwang-Soo Kim et al. ACS Applied Materials & Interfaces
- Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer
- (2020) Jingjing Sun et al. BIOMATERIALS
- Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors
- (2020) M.E. Lorkowski et al. JOURNAL OF CONTROLLED RELEASE
- Broadening the impact of immunotherapy to pancreatic cancer: Challenges and opportunities
- (2019) Vinod P. Balachandran et al. GASTROENTEROLOGY
- Early and late hematologic toxicity following CD19 CAR-T cells
- (2019) Shalev Fried et al. BONE MARROW TRANSPLANTATION
- Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
- (2019) Seon Ah Lim et al. Frontiers in Immunology
- Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer
- (2019) Eunsung Jun et al. Frontiers in Immunology
- Checkpoint inhibitors in pancreatic cancer
- (2019) Andreas Henriksen et al. CANCER TREATMENT REVIEWS
- CD8+CD28− T cells: key cytotoxic players impacting disease pathogenesis in chronic HBV infection
- (2019) Madhuparna Nandi et al. CLINICAL SCIENCE
- Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
- (2019) Akintunde Akinleye et al. Journal of Hematology & Oncology
- Robo1-specific CAR-NK Immunotherapy Enhances Efficacy of 125I Seed Brachytherapy in an Orthotopic Mouse Model of Human Pancreatic Carcinoma
- (2019) NING XIA et al. ANTICANCER RESEARCH
- Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
- (2019) Huang Zhu et al. BLOOD
- Polysaccharide enhanced NK cell cytotoxicity against pancreatic cancer via TLR4/MAPKs/NF-κB pathway in vitro/vivo
- (2019) Xin Xie et al. CARBOHYDRATE POLYMERS
- Trans-endocytosis of intact IL-15Rα–IL-15 complex from presenting cells into NK cells favors signaling for proliferation
- (2019) Olga M. Anton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer
- (2018) Mayumi Hoshikawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression
- (2018) Rika Fujii et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice
- (2018) Virender Kumar et al. Theranostics
- Cytokine release syndrome
- (2018) Alexander Shimabukuro-Vornhagen et al. Journal for ImmunoTherapy of Cancer
- Tumor microenvironment participates in metastasis of pancreatic cancer
- (2018) Bo Ren et al. Molecular Cancer
- The IL-15–AKT–XBP1s signaling pathway contributes to effector functions and survival in human NK cells
- (2018) Yufeng Wang et al. NATURE IMMUNOLOGY
- Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
- (2018) Brian J. Christmas et al. Cancer Immunology Research
- IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer
- (2017) M. Felices et al. GYNECOLOGIC ONCOLOGY
- Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer
- (2017) Mao Lin et al. IMMUNOLOGY LETTERS
- Recent progress in GM-CSF-based cancer immunotherapy
- (2017) Wan-Lun Yan et al. Immunotherapy
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma
- (2017) Qi Wu et al. Oncotarget
- The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis
- (2017) Geou-Yarh Liou et al. Cell Reports
- Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs
- (2017) Anna Kozlowska et al. Journal of Cancer
- The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
- (2017) Chunwan Lu et al. JNCI-Journal of the National Cancer Institute
- The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
- (2017) Sourav Paul et al. Frontiers in Immunology
- Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).
- (2017) R. F. Gabitass et al. JOURNAL OF CLINICAL ONCOLOGY
- The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis
- (2017) Hirayuki Enomoto et al. Scientific Reports
- Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis
- (2016) Virender Kumar et al. BIOMATERIALS
- IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
- (2016) Elizabeth L. McMichael et al. CLINICAL CANCER RESEARCH
- Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies
- (2016) Jun-ichi Masuyama et al. CYTOTHERAPY
- Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages
- (2016) Qiaofei Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
- (2016) Qian Chen et al. Nature Communications
- Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein
- (2016) Xiansheng Lin et al. Oncotarget
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
- (2016) Takashi Nakamura et al. Scientific Reports
- Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach
- (2015) Jeremiah L. Oyer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer
- (2015) Goutam Mondal et al. BIOMACROMOLECULES
- Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells
- (2015) A. Lo et al. CANCER RESEARCH
- Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
- (2015) S. Takeuchi et al. CANCER RESEARCH
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- PTEN Is a Negative Regulator of NK Cell Cytolytic Function
- (2015) Edward L. Briercheck et al. JOURNAL OF IMMUNOLOGY
- Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology
- (2015) Andreas Heindl et al. LABORATORY INVESTIGATION
- Codelivery of Small Molecule Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer
- (2015) Virender Kumar et al. MOLECULAR PHARMACEUTICS
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
- (2015) Pawel K Mazur et al. NATURE MEDICINE
- Targeting Siglecs with a sialic acid–decorated nanoparticle abrogates inflammation
- (2015) Shaun Spence et al. Science Translational Medicine
- Adoptive cellular therapy: A race to the finish line
- (2015) Carl H. June et al. Science Translational Medicine
- IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
- (2015) Serena Lunardi et al. Oncotarget
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
- (2014) Priyanka Sathe et al. Nature Communications
- Mutant KRAS–Induced Expression of ICAM-1 in Pancreatic Acinar Cells Causes Attraction of Macrophages to Expedite the Formation of Precancerous Lesions
- (2014) Geou-Yarh Liou et al. Cancer Discovery
- The Critical Role of IL-15–PI3K–mTOR Pathway in Natural Killer Cell Effector Functions
- (2014) Neethi Nandagopal et al. Frontiers in Immunology
- Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
- (2013) E. M. Dijkgraaf et al. CANCER RESEARCH
- Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma
- (2013) Abasi Ene–Obong et al. GASTROENTEROLOGY
- IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
- (2013) Georg Gasteiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors
- (2013) Ilona Hromadnikova et al. MEDIATORS OF INFLAMMATION
- Pancreatic cancer-associated stellate cells
- (2013) Thomas A Mace et al. OncoImmunology
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia
- (2012) Yuliya Pylayeva-Gupta et al. CANCER CELL
- Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
- (2012) R. Shakya et al. CANCER RESEARCH
- EZH2 couples pancreatic regeneration to neoplastic progression
- (2012) J. Mallen-St. Clair et al. GENES & DEVELOPMENT
- DNA Methylation and Its Basic Function
- (2012) Lisa D Moore et al. NEUROPSYCHOPHARMACOLOGY
- High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer
- (2011) Dong Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Unifying concepts of MHC-dependent natural killer cell education
- (2011) Julie M. Elliott et al. TRENDS IN IMMUNOLOGY
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- NK cell education: not an on-off switch but a tunable rheostat
- (2009) Petter Brodin et al. TRENDS IN IMMUNOLOGY
- How Diverse--CD4 Effector T Cells and their Functions
- (2009) Y. Y. Wan et al. Journal of Molecular Cell Biology
- Beyond licensing and disarming: A quantitative view on NK-cell education
- (2008) Petter Brodin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibitory Receptor Signaling via Tyrosine Phosphorylation of the Adaptor Crk
- (2008) Mary E. Peterson et al. IMMUNITY
- Memory CD4 T cells emerge from effector T-cell progenitors
- (2008) Laurie E. Harrington et al. NATURE
- Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
- (2008) A. M. Unni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-21 activates human natural killer cells and modulates their surface receptor expression
- (2007) Kresten Skak et al. IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now